跳至主要内容
临床试验/NCT06917040
NCT06917040已完成3 期

Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria

The Mentor Initiative1 个研究点 分布在 1 个国家目标入组 18,404 人开始时间: 2021年2月1日最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
18,404
试验地点
1
主要终点
Entomological outcome: phlebotomine sandfly density

研究概览

简要总结

The aim of this study is to determine the efficacy of Mosquito Shield (spatial repellent) in reducing cutaneous leishmaniasis case incidence among internally displaced persons and sandfly density in temporary shelters and camp settings in Ar-Raqqa governorate, North-East Syria.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

盲法说明

Neither the deliverers of the intervention nor the outcome assessors are blinded to the group allocations

入排标准

性别
All
接受健康志愿者

入选标准

  • Known history of cutaneous leishmaniasis in camp Sleeping under same shelter type (all UNHCR tents / plastic sheets) Camp easily accessible by road Camps a minimum of 5km apart Adequate security levels

排除标准

  • Camps closer than 5km from a camp included in the study Camps with no previously recorded cases of cutaneous leishmaniasis Displaced communities living outside of defined camp settings

结局指标

主要结局

Entomological outcome: phlebotomine sandfly density

时间窗: 9 months

Phlebotomine sandfly density will be estimated monthly using Centers for Disease Control and Prevention light traps inside shelters.

Epidemiological outcome: cutaneous leishmaniasis incidence

时间窗: 11 or 9 months

Cutaneous leishmaniasis incidence per 1,000 will be estimated as the total number of cutaneous leishmaniasis episodes per 1,000 persons over the course of the trial. Two different incubation times or diagnostic cut-offs will be used: at 2 months post-intervention (from August 2021 to April 2022) and at 4 months post-intervention (from August 2021 to April 2022).

次要结局

  • Intervention feasibility, acceptability and uptake(11 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Richard Allan

Principal Investigator

The Mentor Initiative

研究点 (1)

Loading locations...

相似试验